Previous 10 | Next 10 |
2024-02-06 19:32:41 ET Summary Madrigal Pharmaceuticals is leading the race to secure approval for its drug Resmetirom to treat NASH, now known as MASH, a form of fatty liver disease. Eli Lilly's drug tirzepatide, which has already secured approvals for Type 2 diabetes and obesity...
2024-02-06 16:47:04 ET Eli Lilly and Co (LLY) Q4 2024 Earnings Conference Call February 06, 2024, 10:00 AM ET Company Participants Joe Fletcher - SVP, IR David Ricks - Chairman, CEO & President Anat Ashkenazi - EVP & CFO Daniel Skovronsky - Chief Scie...
2024-02-06 16:16:24 ET More on Catalent Catalent: Debt Remains An Overhang Catalent, Inc. (CTLT) Q1 2024 Earnings Call Transcript Catalent, Inc. 2024 Q1 - Results - Earnings Call Presentation Lilly reportedly worried about impact of Catalent/Novo deal ...
2024-02-06 13:23:49 ET More on Catalent, Eli Lilly, etc. Eli Lilly and Company 2023 Q4 - Results - Earnings Call Presentation Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value Novo Nordisk A/S (NVO) Q4 2023 Earnings Call Transcript ...
2024-02-06 12:58:10 ET More on Akero Therapeutics, 89bio, etc. Biotech And Pharma Diversification Pays Off Sagimet: Additional Upside Possible After Latest NASH Data Release Madrigal Pharmaceuticals: A Deeper Look At A Looming NASH Play Karuna’s KarXT ...
2024-02-06 11:41:40 ET Shares of Eli Lilly (NYSE: LLY) jumped as much as 5.1% on Tuesday. However, as of 11:37 a.m. ET, the big pharma stock was down by 0.5%. The initial spike came after Lilly announced its 2023 fourth-quarter and full-year results. The company reported Q4 reve...
2024-02-06 09:15:00 ET U.S. stock index futures on Tuesday pointed to a slightly higher open, as market participants geared up for a host of Federal Reserve speakers through the day. The central bank last week pushed back against rate cut expectations. Here are some stocks to watch on T...
A look at the top 10 most actives in the United States Phunware Inc. (PHUN) rose 19.9% to $0.41 on volume of 260,182,609 shares Palantir Technologies Inc. Class A (PLTR) fell 1.8% to $16.72 on volume of 167,698,349 shares PROSHARES TRUST (SQQQ) rose 0.5% to $11.78 on volume of 155,646,888...
S&P 500 futures hovered around the flatline Tuesday following a selloff spurred by higher bond yields and worries that the Federal Reserve may not cut rates as much as Wall Street had hoped. Futures for the Dow Jones Industrials index subsided 13 points to 38,453. Futures for the S&am...
2024-02-06 07:28:18 ET More on Eli Lilly, Eli Lilly and Company, etc. Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value Biotech And Pharma Diversification Pays Off Eli Lilly: The Cupboard Is Fully Stocked Eli Lilly beats in Q4 a...
News, Short Squeeze, Breakout and More Instantly...
2024-07-29 15:13:21 ET Eli Lilly & Co (NYSE: LLY) has recently experienced a dramatic $123 billion decline in market value. This significant drop follows positive developments from competitors, notably Viking Therapeutics Inc and Roche Holding AG, who made announcements regarding th...
2024-07-29 09:20:00 ET While the market for anti-obesity medicines is characterized today by a fight between Novo Nordisk 's (NYSE: NVO) drug Wegovy and Eli Lilly 's (NYSE: LLY) drug Zepbound, that won't always be the case. Over the coming years, the competitive dynamics of ...
2024-07-29 07:30:00 ET When a major player announces good news in a lucrative market like weight loss drugs, it's often enough to drive shares of competitors down based on the assumption that they will have struggles ahead. That's just what happened after an announcement by Roche Hold...